AMLX Amylyx Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ 10-K/10-Q Aug 6, 2026
$28,13
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$10,8852-Wochen-Tief
$41,1452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$3.13B
P/E
-18.6
EPS
$-1.53
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$11–$41
Analystenbewertung
STRONG BUY
Kursziel
$43
P/E
-18.6
ROE
-61.2%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
AMLX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$28.13
Marktkapitalisierung (MRQ)
$3.13B
P/E
-18.6
EPS
$-1.53
Umsatz
$0
ROE
-61.2%
52W-Spanne
$11–$41
AMLX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02021-12-31 → 2025-12-31
EPS$-1.532021-12-31 → 2025-12-31
Freier Cashflow$-123M2022-12-31 → 2025-12-31
Nettogewinnmarge·2022-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | AMLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -18.65-Jahres-Durchschnitt ≈0.3 | ≈0.3 | · | · | |
| K/B (MRQ) | 13.15-Jahres-Durchschnitt ≈3.9 | ≈3.9 | 6.9 | Überbewertet | |
| Price / FCF (Kurs / FCF) | -25.35-Jahres-Durchschnitt ≈16.9 | ≈16.9 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -25.35-Jahres-Durchschnitt ≈14.4 | ≈14.4 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 10.25-Jahres-Durchschnitt ≈3.9 | ≈3.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | AMLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -55.0%5-Jahres-Durchschnitt ≈-52.2% | ≈-52.2% | -24.7% | Schwach | |
| ROE | -61.2%5-Jahres-Durchschnitt ≈-74.7% | ≈-74.7% | -21.9% | Schwach | |
| ROIC | -50.2%5-Jahres-Durchschnitt ≈-73.1% | ≈-73.1% | -17.6% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | AMLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 12.15-Jahres-Durchschnitt ≈8.7 | ≈8.7 | 6.9 | Starke Liquidität | |
| Quick Ratio | 14.05-Jahres-Durchschnitt ≈8.2 | ≈8.2 | 3.1 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | AMLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -77.1%5-Jahres-Durchschnitt ≈3078.6% | ≈3078.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 574.3% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | AMLX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.5 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 0.05-Jahres-Durchschnitt ≈5.2 | ≈5.2 | 4.9 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
5.6%
Nächster Bericht
Nov 05, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.39 | $-0.37 | -5.9% |
| 31. März 2026 | Mai 7, 2026 | $-0.37 | $-0.34 | -9.8% |
| 31. Dezember 2025 | $-0.30 | $-0.37 | 18.0% | |
| 30. September 2025 | $-0.37 | $-0.46 | 19.4% | |
| 30. Juni 2025 | $-0.46 | $-0.45 | -1.3% | |
| 31. März 2025 | $-0.42 | $-0.48 | 13.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $87M | $381M | $22M | $285.0K | |
| Cost of Revenue | $0 | $6M | $25M | $3M | · | |
| R&D Expense | $90M | $104M | $128M | $93M | $44M | |
| SG&A Expense | $63M | $114M | $188M | $127M | $39M | |
| Operating Expenses | $153M | $402M | $342M | $224M | $83M | |
| Operating Income | $-153M | $-315M | $39M | $-201M | $-83M | |
| Interest Income | $9M | $14M | $16M | $4M | $36.0K | |
| Other Non-op | $-700.0K | $-1M | $-660.0K | $-551.0K | $-51.0K | |
| Pretax Income | $-145M | $-302M | $54M | $-198M | $-88M | |
| Income Tax | $46.0K | $-393.0K | $5M | $774.0K | · | |
| Net Income | $-145M | $-302M | $49M | $-198M | $-88M | |
| EPS (Basic) | $-1.53 | $-4.43 | $0.73 | $-3.39 | $-13.35 | |
| EPS (Diluted) | $-1.53 | $-4.43 | $0.70 | $-3.39 | $-13.35 | |
| Shares (Basic) | 94,565,567 | 68,142,158 | 67,234,465 | 58,495,587 | 6,586,349 | |
| Shares (Diluted) | 94,565,567 | 68,142,158 | 69,991,340 | 58,495,587 | 6,586,349 | |
| EBITDA | $-153M | $-315M | $39M | $-201M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $227M | $77M | $170M | $63M | $50M | |
| Short-term Investments | $90M | $99M | $201M | $284M | $46M | |
| Receivables | $88.0K | $447.0K | $40M | $15M | · | |
| Inventory | · | · | $38M | $10M | · | |
| Prepaid Expense | $7M | $12M | $15M | $10M | $5M | |
| Current Assets | $324M | $189M | $465M | $382M | $105M | |
| PP&E (Net) | $310.0K | $961.0K | $3M | $3M | $474.0K | |
| PP&E (Gross) | $2M | $2M | $4M | $3M | $527.0K | |
| Accum. Depreciation | $2M | $1M | $2M | $540.0K | $53.0K | |
| Other Non-current Assets | $2M | $24.0K | $701.0K | $466.0K | · | |
| Total Assets | $333M | $194M | $517M | $391M | $106M | |
| Accounts Payable | $4M | $3M | $22M | $6M | $4M | |
| Accrued Liabilities | $18M | $24M | $58M | $38M | · | |
| Current Liabilities | $23M | $28M | $82M | $47M | $17M | |
| Capital Leases | $5M | $463.0K | $2M | $4M | · | |
| Total Liabilities | $27M | $29M | $84M | $51M | $17M | |
| Common Stock | $11.0K | $7.0K | $7.0K | $7.0K | $1.0K | |
| Retained Earnings | $-751M | $-607M | $-305M | $-354M | $-156M | |
| AOCI | $404.0K | $-92.0K | $197.0K | $-86.0K | $9.0K | |
| Stockholders' Equity | $305M | $165M | $433M | $341M | $-151M | |
| Liabilities + Equity | $333M | $194M | $517M | $391M | $106M | |
| Shares Outstanding | 109,884,502 | 68,629,738 | 67,707,432 | 66,512,011 | 7,020,487 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $33M | $37M | $22M | $3M | |
| Restructuring | $0 | $23M | · | · | · | |
| Operating Cash Flow | $-123M | $-168M | $12M | $-180M | $-75M | |
| CapEx | $138.0K | $157.0K | $1M | $3M | $353.0K | |
| Investing Cash Flow | $14M | $76M | $92M | $-239M | $-46M | |
| Financing Cash Flow | $257M | $348.0K | $4M | $432M | $159M | |
| Net Change in Cash | $149M | $-92M | $108M | $13M | $37M | |
| Taxes Paid | $-1M | $235.0K | · | · | · | |
| Free Cash Flow | $-123M | $-168M | $11M | $-182M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | · | -360.2% | 10.2% | -905.7% | · | |
| Net Margin | · | -345.4% | 12.9% | -892.4% | · | |
| Pretax Margin | · | -345.8% | 14.3% | -888.9% | · | |
| EBITDA Margin | · | -360.2% | 10.2% | -905.7% | · | |
| ROA | -55.0% | -84.9% | 10.8% | -79.8% | · | |
| ROE | -61.2% | -167.2% | 11.6% | -81.9% | · | |
| ROIC | -50.2% | -190.8% | 8.1% | -59.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | 6.7 | 5.7 | 8.2 | · | |
| Quick Ratio | 14.0 | 6.2 | 5.0 | 7.8 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | 0.8 | 0.1 | · | |
| Inventory Turnover | · | · | 1.1 | 0.6 | · | |
| Receivables Turnover | 0.0 | 4.3 | 13.8 | 2.9 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $2.78 | $2.40 | $6.40 | $5.12 | · | |
| Revenue / Share | $0.00 | $1.28 | $5.44 | $0.38 | · | |
| Cash Flow / Share | $-1.30 | $-2.46 | $0.17 | $-3.07 | · | |
| Cash / Share | $2.06 | $1.13 | $2.51 | $0.94 | · | |
| EPS (TTM) | $-1.53 | $-4.43 | $0.70 | $-3.39 | $-13.35 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | -77.1% | 1612.9% | 7700.0% | · | |
| Revenue CAGR 3Y | · | 574.3% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $87M | $381M | $22M | $285.0K | |
| Net Income TTM | $-145M | $-302M | $49M | $-198M | $-88M | |
| Market Cap | $1.33B | $259M | $997M | $2.46B | · | |
| P/E | -7.9 | -0.9 | 21.0 | -10.9 | · | |
| P/S | · | 3.0 | 2.6 | 110.6 | · | |
| P/B | 4.3 | 1.6 | 2.3 | 7.2 | · | |
| P / Tangible Book | 4.3 | 1.6 | 2.3 | 7.2 | · | |
| P / Cash Flow | -10.8 | -1.5 | 83.6 | -13.7 | · | |
| P / FCF | -10.7 | -1.5 | 93.3 | -13.5 | · | |
| Earnings Yield | -12.7% | -117.2% | 4.8% | -9.2% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $-665.0K | $416.0K | $-1M | $89M | $108M | $103M | $98M | $71M | $22M | $345.0K | |
| Cost of Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $8.0K | $6M | $9M | $5M | $6M | $5M | $3M | $172.0K | |
| R&D Expense | $24M | $28M | $21M | $20M | $27M | $22M | $23M | $21M | $23M | $37M | $45M | $30M | $29M | $24M | $23M | $25M | |
| SG&A Expense | $22M | $16M | $15M | $16M | $16M | $16M | $17M | $18M | $22M | $58M | $52M | $49M | $43M | $44M | $41M | $30M | |
| Operating Expenses | $46M | $44M | $37M | $36M | $43M | $38M | $40M | $76M | $75M | $211M | $107M | $84M | $78M | $73M | $66M | $55M | |
| Operating Income | $-46M | $-44M | $-37M | $-36M | $-43M | $-38M | $-41M | $-76M | $-76M | $-122M | $2M | $19M | $20M | $-2M | $-45M | $-55M | |
| Interest Income | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $601.0K | |
| Other Non-op | $-53.0K | $-75.0K | $361.0K | $-180.0K | $-546.0K | $-335.0K | $157.0K | $-141.0K | $-483.0K | $-747.0K | $171.0K | $-488.0K | $-81.0K | $-262.0K | $-689.0K | $199.0K | |
| Pretax Income | · | · | $-33M | $-34M | $-41M | $-36M | $-38M | $-73M | $-73M | $-119M | $6M | $22M | $24M | $1M | $-42M | $-54M | |
| Income Tax | · | · | $46.0K | $0 | $0 | $0 | $-635.0K | $0 | $0 | $242.0K | $2M | $2M | $2M | $-170.0K | $579.0K | $-125.0K | |
| Net Income | $-43M | $-41M | $-33M | $-34M | $-41M | $-36M | $-38M | $-73M | $-73M | $-119M | $5M | $21M | $22M | $2M | $-43M | $-54M | |
| EPS (Basic) | $-0.39 | $-0.37 | $-0.28 | $-0.37 | $-0.46 | $-0.42 | $-0.54 | $-1.07 | $-1.07 | $-1.75 | $0.07 | $0.31 | $0.33 | $0.02 | $-0.61 | $-0.92 | |
| EPS (Diluted) | $-0.39 | $-0.37 | $-0.28 | $-0.37 | $-0.46 | $-0.42 | $-0.54 | $-1.07 | $-1.07 | $-1.75 | $0.07 | $0.30 | $0.31 | $0.02 | $-0.61 | $-0.92 | |
| Shares (Basic) | 111,196,883 | 110,563,360 | · | 93,332,930 | 89,138,568 | 85,697,108 | · | 68,091,446 | 68,024,929 | 67,854,356 | · | 67,414,669 | 67,233,617 | 66,717,271 | · | 58,533,226 | |
| Shares (Diluted) | 111,196,883 | 110,563,360 | · | 93,332,930 | 89,138,568 | 85,697,108 | · | 68,091,446 | 68,024,929 | 67,854,356 | · | 69,748,547 | 70,132,040 | 70,863,665 | · | 58,533,226 | |
| EBITDA | $-46M | $-44M | · | $-36M | $-43M | $-38M | · | $-76M | $-76M | $-122M | · | $19M | $20M | $-2M | · | $-55M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $229M | $227M | $225M | $58M | $60M | $77M | $72M | $75M | $171M | $170M | $135M | $248M | $115M | $63M | $108M | |
| Short-term Investments | $201M | $51M | $90M | $119M | $123M | $144M | $99M | $163M | $235M | $203M | $201M | $220M | $110M | $231M | $284M | $55M | |
| Receivables | · | · | $88.0K | $132.0K | $103.0K | $300.0K | $447.0K | $2M | $4M | $20M | $40M | $29M | $33M | $18M | $15M | $137.0K | |
| Inventory | · | · | · | · | · | · | · | · | · | · | $38M | $32M | $25M | $13M | $10M | $563.0K | |
| Prepaid Expense | $6M | $5M | $7M | $9M | $6M | $12M | $12M | $9M | $13M | $17M | $15M | $17M | $12M | $13M | $10M | $8M | |
| Current Assets | $256M | $285M | $324M | $353M | $187M | $216M | $189M | $245M | $327M | $411M | $465M | $434M | $427M | $389M | $382M | $172M | |
| PP&E (Net) | $199.0K | $212.0K | $310.0K | $399.0K | $445.0K | $816.0K | $961.0K | $1M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $4M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $1M | · | · | · | $2M | · | · | · | $540.0K | · | |
| Other Non-current Assets | · | $2M | · | $2M | · | $11.0K | · | $482.0K | $479.0K | $493.0K | $701.0K | $476.0K | $466.0K | $466.0K | $466.0K | $456.0K | |
| Total Assets | $265M | $294M | $333M | $363M | $195M | $220M | $194M | $251M | $332M | $417M | $517M | $467M | $454M | $408M | $391M | $181M | |
| Accounts Payable | $6M | $4M | $4M | $5M | $3M | $5M | $3M | $1M | $5M | $21M | $22M | $6M | $25M | $11M | $6M | $7M | |
| Accrued Liabilities | $15M | $11M | $18M | $19M | $17M | $12M | $24M | $50M | $63M | $68M | $58M | $37M | $37M | $39M | $38M | · | |
| Current Liabilities | $21M | $16M | $23M | $26M | $21M | $18M | $28M | $54M | $70M | $92M | $82M | $46M | $64M | $52M | $47M | $33M | |
| Capital Leases | $4M | $4M | $5M | $5M | $5M | $327.0K | $463.0K | $595.0K | $772.0K | $1M | $2M | $3M | $3M | $4M | $4M | $5M | |
| Total Liabilities | $25M | $20M | $27M | $31M | $27M | $18M | $29M | $55M | $71M | $93M | $84M | $48M | $67M | $55M | $51M | $37M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $9.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | |
| Retained Earnings | $-836M | $-793M | $-751M | $-718M | $-684M | $-643M | $-607M | $-569M | $-496M | $-424M | $-305M | $-310M | $-331M | $-353M | $-354M | $-312M | |
| AOCI | $19.0K | $240.0K | $404.0K | $815.0K | $551.0K | $0 | $-92.0K | $641.0K | $-97.0K | $-77.0K | $197.0K | $-151.0K | $-72.0K | $25.0K | $-86.0K | $-725.0K | |
| Stockholders' Equity | $239M | $273M | $305M | $332M | $168M | $201M | $165M | $196M | $261M | $324M | $433M | $418M | $386M | $353M | $341M | $144M | |
| Liabilities + Equity | $265M | $294M | $333M | $363M | $195M | $220M | $194M | $251M | $332M | $417M | $517M | $467M | $454M | $408M | $391M | $181M | |
| Shares Outstanding | 111,368,283 | 111,026,477 | 109,884,502 | 109,766,382 | 89,156,350 | 89,080,821 | 68,629,738 | 68,545,508 | 68,079,057 | 67,975,587 | 67,707,432 | 67,505,126 | 67,354,417 | 67,095,603 | 66,512,011 | 58,533,226 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $6M | $6M | $7M | $7M | $7M | $7M | $7M | $10M | $10M | $10M | $10M | $10M | $8M | $6M | $6M | |
| Restructuring | · | · | $0 | $0 | $0 | · | $0 | $0 | $23M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-31M | $-37M | $-28M | $-30M | $-25M | $-40M | $-59M | $-42M | $-67M | $-489.0K | $14M | $-5M | $9M | $-5M | $-50M | $-43M | |
| CapEx | · | · | $86.0K | $24.0K | $17.0K | $11.0K | $20.0K | $-19.0K | $89.0K | $67.0K | $356.0K | $357.0K | $278.0K | $250.0K | $620.0K | $459.0K | |
| Investing Cash Flow | $-150M | $36M | $29M | $5M | $23M | $-44M | $65M | $39M | $-29M | $819.0K | $21M | $-108M | $123M | $56M | $-228M | $84M | |
| Financing Cash Flow | $1M | $3M | $-208.0K | $192M | $-31.0K | $66M | $110.0K | $80.0K | $27.0K | $131.0K | $230.0K | $889.0K | $1M | $1M | $232M | $0 | |
| Net Change in Cash | $-180M | $2M | $1M | $167M | $-2M | $-18M | $6M | $-2M | $-96M | $351.0K | $35M | $-113M | $133M | $52M | $-45M | $41M | |
| Taxes Paid | · | · | · | · | $-30.0K | $-30.0K | $499.0K | $17.0K | $-6.0K | $-275.0K | · | $-2M | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-40M | · | · | · | $-556.0K | · | · | · | $-5M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -18187.7% | 7457.1% | -137.8% | · | 18.2% | 20.6% | -2.9% | · | -15849.6% | |
| Net Margin | · | · | · | · | · | · | · | -17476.9% | 7106.6% | -134.0% | · | 20.3% | 22.5% | 2.2% | · | -15581.5% | |
| Pretax Margin | · | · | · | · | · | · | · | -17476.9% | 7106.6% | -133.7% | · | 21.8% | 24.4% | 2.0% | · | -15617.7% | |
| EBITDA Margin | · | · | · | · | · | · | · | -18187.7% | 7457.1% | -137.8% | · | 18.2% | 20.6% | -2.9% | · | -15849.6% | |
| ROA | -18.9% | -16.1% | · | -11.2% | -15.7% | -11.3% | · | -20.3% | -18.5% | -28.8% | · | 6.5% | 6.5% | 0.46% | · | -59.2% | |
| ROE | -21.3% | -17.4% | · | -13.0% | -19.3% | -13.7% | · | -23.7% | -22.4% | -35.1% | · | 7.4% | 7.6% | 0.53% | · | -74.7% | |
| ROIC | · | · | · | -10.8% | -25.5% | -18.8% | · | · | · | -37.7% | · | 4.2% | 4.8% | -0.65% | · | -37.9% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.1 | 17.9 | · | 13.7 | 8.7 | 12.1 | · | 4.5 | 4.7 | 4.5 | · | 9.5 | 6.7 | 7.5 | · | 5.3 | |
| Quick Ratio | 11.9 | 17.5 | · | 13.3 | 8.4 | 11.4 | · | 4.4 | 4.5 | 4.3 | · | 8.4 | 6.1 | 7.0 | · | 5.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | -0.0 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.3 | 0.4 | 0.8 | · | 0.6 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | -0.1 | 4.7 | · | 7.0 | 5.9 | 8.1 | · | 5.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.15 | $2.46 | · | $3.02 | $1.88 | $2.26 | · | $2.86 | $3.84 | $4.77 | · | $6.20 | $5.74 | $5.26 | · | $2.46 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.01 | $-0.01 | $1.31 | · | $1.47 | $1.40 | $1.01 | · | $0.01 | |
| Cash Flow / Share | · | $-0.33 | · | · | · | $-0.46 | · | · | · | $-0.01 | · | · | · | $-0.07 | · | · | |
| Cash / Share | $0.44 | $2.06 | · | $2.05 | $0.65 | $0.67 | · | $1.05 | $1.10 | $2.51 | · | $2.00 | $3.68 | $1.71 | · | $1.84 | |
| EPS (TTM) | $-1.41 | $-1.48 | · | $-1.79 | $-2.49 | $-3.10 | · | $-3.82 | $-2.45 | $-1.07 | · | $0.02 | $-1.20 | $-2.44 | · | $-6.93 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $-665.0K | $-249.0K | $-1M | · | $196M | $299M | $398M | · | $294M | $192M | · | · | · | |
| Net Income TTM | $-152M | $-150M | · | $-149M | $-188M | $-219M | · | $-259M | $-166M | $-71M | · | $2M | $-73M | $-149M | · | $-184M | |
| Market Cap | $2.00B | $1.54B | · | $1.49B | $571M | $315M | · | $222M | $129M | $193M | · | $1.24B | $1.45B | $1.97B | · | $1.65B | |
| P/E | -12.7 | -9.4 | · | -7.6 | -2.6 | -1.1 | · | -0.8 | -0.8 | -2.7 | · | 915.5 | -18.0 | -12.0 | · | -4.1 | |
| P/S | · | · | · | -2243.2 | -2295.1 | -247.9 | · | 1.1 | 0.4 | 0.5 | · | 4.2 | 7.6 | · | · | · | |
| P/B | 8.4 | 5.6 | · | 4.5 | 3.4 | 1.6 | · | 1.1 | 0.5 | 0.6 | · | 3.0 | 3.8 | 5.6 | · | 11.4 | |
| P / Tangible Book | 8.4 | 5.6 | · | 4.5 | 3.4 | 1.6 | · | 1.1 | 0.5 | 0.6 | · | 3.0 | 3.8 | 5.6 | · | 11.4 | |
| P / Cash Flow | · | -41.8 | · | · | · | -7.9 | · | · | · | -394.8 | · | · | · | -388.1 | · | · | |
| Earnings Yield | -7.8% | -10.7% | · | -13.2% | -38.9% | -87.6% | · | -117.9% | -129.0% | -37.7% | · | 0.11% | -5.6% | -8.3% | · | -24.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $0 | $87M | $381M | $22M | $285.0K |
| Betriebsgewinnmarge % | · | -360.2% | 10.2% | -905.7% | · |
| Nettoergebnis | $-145M | $-302M | $49M | $-198M | $-88M |
| Verwässerte EPS | $-1.53 | $-4.43 | $0.70 | $-3.39 | $-13.35 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 14.3 | 6.7 | 5.7 | 8.2 | · |
| Quick Ratio | 14.0 | 6.2 | 5.0 | 7.8 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-123M | $-168M | $11M | $-182M | · |
Institutionelle Eigentümer (13F) 230 Einreicher · $2.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
230
Gehaltener Wert
$2.1B
Neue Positionen
55
Geschlossene Positionen
13
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 55 (+23 vs. Vorquartal) | 13 (-20 vs. Vorquartal) | 74 (+7 vs. Vorquartal) | 62 (+7 vs. Vorquartal) | -4.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $300.433.246 | 16.727.909 | 14,18% | Aktien |
| BlackRock, Inc. | $158.534.442 | 8.827.085 | 7,48% | Aktien |
| PERCEPTIVE ADVISORS LLC | $149.694.481 | 8.334.882 | 7,06% | Aktien |
| TCG Crossover Management, LLC | $112.138.864 | 6.243.812 | 5,29% | Aktien |
| Commodore Capital LP | $101.474.000 | 5.650.000 | 4,79% | Aktien |
| Saturn V Capital Management LP | $83.048.854 | 4.624.101 | 3,92% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $75.867.063 | 4.224.224 | 3,58% | Aktien |
| VANGUARD GROUP INC | $70.123.336 | 5.804.912 | 3,31% | Aktien |
| JANUS HENDERSON GROUP PLC | $69.256.554 | 4.986.073 | 3,27% | Aktien |
| MORGAN STANLEY | $56.229.311 | 3.130.808 | 2,65% | Aktien |
| Driehaus Capital Management LLC | $54.543.981 | 3.036.970 | 2,57% | Aktien |
| First Light Asset Management, LLC | $54.297.678 | 3.023.256 | 2,56% | Aktien |
| FRANKLIN RESOURCES INC | $52.986.040 | 2.950.225 | 2,50% | Aktien |
| GOLDMAN SACHS GROUP INC | $51.333.972 | 2.858.239 | 2,42% | Aktien |
| STATE STREET CORP | $46.755.933 | 2.603.337 | 2,21% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $41.949.140 | 2.335.315 | 1,98% | Aktien |
| JPMORGAN CHASE & CO | $34.921.895 | 1.863.650 | 1,65% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $34.124.000 | 1.900.000 | 1,61% | Aktien |
| Siren, L.L.C. | $26.591.325 | 1.480.586 | 1,25% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $23.844.428 | 1.327.536 | 1,13% | Aktien |
| 683 Capital Management, LLC | $22.980.036 | 1.279.512 | 1,08% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19.065.151 | 1.061.534 | 0,90% | Aktien |
| Alyeska Investment Group, L.P. | $18.912.149 | 1.053.015 | 0,89% | Aktien |
| Almitas Capital LLC | $17.508.863 | 974.881 | 0,83% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $16.215.061 | 902.463 | 0,77% | Aktien |
| Jones Hill Capital LP | $16.057.282 | 894.058 | 0,76% | Aktien |
| Woodline Partners LP | $15.201.111 | 846.387 | 0,72% | Aktien |
| NORTHERN TRUST CORP | $14.938.051 | 831.740 | 0,70% | Aktien |
| BANK OF AMERICA CORP /DE/ | $14.760.265 | 821.841 | 0,70% | Aktien |
| Boxer Capital Management, LLC | $14.368.000 | 800.000 | 0,68% | Aktien |
| Aberdeen Group plc | $13.248.553 | 737.670 | 0,63% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.021.539 | 725.030 | 0,61% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $12.949.196 | 721.002 | 0,61% | Aktien |
| GREAT POINT PARTNERS LLC | $12.572.000 | 700.000 | 0,59% | Aktien |
| Balyasny Asset Management L.P. | $12.302.133 | 684.974 | 0,58% | Aktien |
| Qube Research & Technologies Ltd | $12.237.746 | 681.389 | 0,58% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $11.190.481 | 623.078 | 0,53% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $10.658.093 | 593.435 | 0,50% | Aktien |
| DEUTSCHE BANK AG\ | $10.020.549 | 557.937 | 0,47% | Aktien |
| Rock Springs Capital Management LP | $8.975.761 | 499.764 | 0,42% | Aktien |
| ADAR1 Capital Management, LLC | $8.879.029 | 494.378 | 0,42% | Aktien |
| Nantahala Capital Management, LLC | $8.740.845 | 486.684 | 0,41% | Aktien |
| FEDERATED HERMES, INC. | $8.301.202 | 462.205 | 0,39% | Aktien |
| Nearwater Capital Markets, Ltd | $7.633.000 | 425.000 | 0,36% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.279.188 | 405.300 | 0,34% | Kaufoption |
| Parkman Healthcare Partners LLC | $7.162.125 | 398.782 | 0,34% | Aktien |
| HighVista Strategies LLC | $6.933.997 | 386.080 | 0,33% | Aktien |
| STEMPOINT CAPITAL LP | $6.902.100 | 384.304 | 0,33% | Aktien |
| Logos Global Management LP | $6.286.000 | 350.000 | 0,30% | Aktien |
| Trexquant Investment LP | $6.275.924 | 349.439 | 0,30% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Morningside Venture Investments Limited (2), MVIL, LLC (2), Frances Anne Elizabeth Richard (2), Jill Marie Franklin (2), Peter Stuart Allenby Edwards (2), Cheung Ka Ho (2), Cheng Yee Wing Betty (2), Wong See Wai (2) ×5 Einreichungen | 4. Oktober 2023 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 15 Insider · 7 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joshua B Cohen | Co-Chief Executive Officer | 10. September 2026 S | 3.613.123 | 0 | 7 | $-3.595.897 |
| Justin B. Klee | Co-Chief Executive Officer | 10. September 2026 S | 3.613.056 | 0 | 7 | $-3.594.312 |
| James M Frates | Chief Financial Officer | 10. September 2026 S | 233.625 | 0 | 5 | $-553.740 |
| Gina Mazzariello | Chief Legal Officer | 10. September 2026 S | 190.838 | 0 | 7 | $-1.046.732 |
| Camille L Bedrosian | Chief Medical Officer | 10. September 2026 S | 278.064 | 0 | 4 | $-513.457 |
| Patrick D Yeramian | Chief Medical Officer | 9. Januar 2024 S | 205.605 | 0 | 0 | $0 |
| Margaret Olinger | Chief Commercial Officer | 27. Dezember 2023 M | 276.108 | 0 | 0 | $0 |
| George M Milne JR | Direktor | 5. Oktober 2026 S | 782.881 | 0 | 1 | $-831.000 |
| Karen Firestone | Direktor | 31. August 2026 M | 116.900 | 2 | 0 | $152.183 |
| Bernhardt G Zeiher | Direktor | 4. Juni 2026 A | 10.000 | 0 | 0 | $0 |
| Paul R. Fonteyne | Direktor | 4. Juni 2026 A | 3.947 | 0 | 0 | $0 |
| Daphne Quimi | Direktor | 4. Juni 2026 A | 5.000 | 0 | 0 | $0 |
| Isaac Cheng | Direktor | 9. Juni 2022 A | 6.578 | 0 | 0 | $0 |
| Morningside Venture Investments Ltd | 10%-Eigentümer | 15. August 2023 G | 4.997.302 | 0 | 0 | $0 |
| ALS Invest 1 B.V. | 10%-Eigentümer | 6. Juli 2022 S | 5.895.280 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 39 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,72% | 17.451 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,93% | 21.303 NS | 31. Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,73% | 366.318 SH | 11. September 2026 | Täglich |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,54% | 8.203 NS | 31. August 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 48.343 SH | 23. Oktober 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,31% | 195.440 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,25% | 810.880 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,24% | 9.430 SH | 23. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,22% | 971.856 SH | 11. September 2026 | Täglich |
| ESSC · Strategy Shares | 0,18% | 3.189 NS | 31. Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,14% | 97.142 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,13% | 145.454 SH | 19. August 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,11% | 82.688 NS | 31. Juli 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,11% | 70.505 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,11% | 2.652.078 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 98.590 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,07% | 63.750 SH | 23. Oktober 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 22.403 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 17.705 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 53.699 SH | 10. September 2026 | Täglich |
| RSSL · Global X Funds | 0,06% | 43.949 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 529.383 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 5.013 SH | 10. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34.142 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 966.947 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 216.297 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,02% | 148.485 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 115.603 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 24.186 SH | 10. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 4.500 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 54.057 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 13.188 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 8.949 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.154.723 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.178 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 8 NS | 31. Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 3.700 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 18.288 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 88.069 SH | 11. September 2026 | Täglich |
AMLX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$42.00
+49,3%
9 50,0%
Starker Kauf
7 38,9%
Kauf
2 11,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-10-28Mittelwert-Ziel $43.00 +52,9%
Jetzt
Aktueller Preis $28.13
Tief$20.00
Mittelwert$43.00
Hoch$57.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AMLX | $1.33B | -7.9 | -77.1% | · | -61.2% | · |
| DFTX | $1.32B | -6.5 | 212.0% | · | -71.0% | · |
| EWTX | $2.64B | -15.2 | · | · | -30.2% | · |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | · |
| INDV | · | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | · |
| ELVN | $915M | -8.4 | · | · | -21.9% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| MBX | $1.42B | -13.3 | · | · | -29.6% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026